RPMI-1640
货号: PM150110
Price: ¥58
产品信息
产品简介 | RPMI-1640是Moore等人于1967年在美国纽约州法罗市的罗斯韦尔公园纪念研究所(Roswell Park Memorial Institute, RPMI)开发出来的,RPMI是该研究所开发的一类细胞培养基,1640是培养基代号。RPMI-1640是改进型的McCoy's 5A培养基,使用碳酸氢盐缓冲系统,与大多数哺乳动物细胞培养基不同的是其典型的PH8的配方。RPMI-1640培养基最初是为淋巴细胞培养专门设计的,现在已广泛应用于各种正常细胞和癌细胞的培养,尤其是悬浮细胞的培养,是使用最为广泛的培养基之一。 本产品含有多类细胞培养所需的氨基酸、维生素、无机盐等多种成分,但不含蛋白质、脂类或任何生长因子,故此产品需搭配血清或无血清添加物使用。 |
产品浓度 | 1× |
产品规格 | 500 mL |
PH | 7.2-7.4 |
D-葡萄糖 | 2000mg/L |
HEPES | 无 |
L-谷氨酰胺 | 2mM |
NaHCO3 | 2000mg/L |
酚红 | 5mg/L |
内毒素含量(EU/mL) | <3 |
储存条件 | 2-8℃,避光储存 |
运输条件 | 常温 |
注意事项 |
|
-
“Closed-Loop” O2-Economizer Induced In Situ Therapeutic Vaccine against Hypoxic Tumors(2023)
期刊:ACS Nano
影响因子:17.100
引用产品: RPMI-1640, Fetal Bovine Serum
-
Hyperthermia-triggered biomimetic bubble nanomachines(2023)
期刊:Nature Communications
DOI:10.1038/s41467-023-40474-9
影响因子:16.600
引用产品: DMEM (High glucose) Complete Medium (10), 4T1 Cells Line, RPMI-1640
-
Remodeling Collagen Microenvironment in Liver Using a Biomimetic Nano-Regulator for Reversal of Liver Fibrosis(2023)
期刊:Advanced Science
影响因子:15.100
引用产品: DMEM/F12, 1 M HEPES Solution, AML12 Cells Complete Medium, RPMI-1640
-
Study on the Role of an Erythrocyte Membrane-Coated Nanotheranostic System in Targeted Immune Regulation of Alzheimer's Disease(2023)
期刊:Advanced Science
影响因子:15.100
引用产品: DMEM(High glucose), RPMI-1640, Fetal Bovine Serum, BV2 Cells Line
-
Osteoclast-derived apoptotic bodies inhibit naive CD8+ T?cell activation via Siglec15, promoting breast cancer secondary metastasis(2023)
期刊:Cell Reports Medicine
DOI:10.1016/j.xcrm.2023.101165
影响因子:14.300
引用产品: RPMI-1640 Medium, EMT6 [EMT-6] Cells Line, 293T [HEK-293T] Cells Line, THP-1 Cells Line, DMEM (High glucose) Medium, 4T1 Cells Line
-
Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer(2023)
期刊:BIOMATERIALS
DOI:10.1016/j.biomaterials.2023.122283
影响因子:14.000
引用产品: Phosphate Buffer (PBS), DMEM(High glucose), RPMI-1640, B16-F10 Cells Line, RAW 264.7 Cells Line
-
Microbubbles-assisted ultrasonication to promote tumor accumulation of therapeutics and modulation of tumor microenvironment for enhanced cancer treatments(2023)
期刊:BIOMATERIALS
DOI:10.1016/j.biomaterials.2023.122181
影响因子:14.000
引用产品: CT26.WT Cells Line, Human Umbilical Vein Endothelial cells, RPMI-1640
-
Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment(2023)
期刊:BIOMATERIALS
DOI:10.1016/j.biomaterials.2023.122392
影响因子:14.000
引用产品: RPMI-1640 Medium
-
Role of macrophage AHR/TLR4/STAT3 signaling axis in the colitis induced by non-canonical AHR ligand aflatoxin B1(2023)
期刊:JOURNAL OF HAZARDOUS MATERIALS
DOI:10.1016/j.jhazmat.2023.131262
影响因子:13.600
引用产品: RPMI-1640, 200 mM L-Glutamine Solution, 100×, β-Mercaptoethanol, 1 M HEPES Solution, MEM Non-Essential Amino Acid Solution (NEAA), 100×
-
Enhanced Osteolysis Targeted Therapy through Fusion of Exosomes Derived from M2 Macrophages and Bone Marrow Mesenchymal Stem Cells: Modulating Macrophage Polarization(2023)
期刊:Small
影响因子:13.300
引用产品: Penicillin-Streptomycin Solution, 100×, RPMI-1640, RAW 264.7 Cells Line, Fetal Bovine Serum

识别码示意图